Merck says antiviral pill effective against COVID-19, lifting hopes for first oral drug
The drugmaker, along with partner Ridgeback Biotherapeutics, plan to ask the FDA for emergency authorization “as soon as possible.”
The drugmaker, along with partner Ridgeback Biotherapeutics, plan to ask the FDA for emergency authorization “as soon as possible.”